Moses Lake Pharmacy Recalls Testosterone Pellets Due to Sterility Concerns
JD & SN Inc. is recalling 50 mg testosterone pellets because the FDA cannot ensure the sterile compounded drugs are free from contamination.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II, and the rubric specifies that FDA Class II recalls with potential for significant injury or hospitalization (implied by lack of sterility assurance in compounded drugs) are rated as Severe.
Plain-English summary
JD & SN Inc., doing business as Moses Lake Professional Pharmacy, is recalling 50 mg testosterone pellets. The recall is being conducted because the U.S. Food and Drug Administration (FDA) has determined that there is a lack of assurance of sterility for these sterile human compounded drugs. The affected products are prescription-only and were distributed nationwide.
The recall covers specific lots of the medication, identified by codes such as t12292014@30 and t11202014@11. The source text indicates that the issue applies to all sterile human compounded drugs within their expiry dates. Consumers and healthcare providers should check their inventory for these specific lot codes.
Individuals who have received these testosterone pellets should contact their healthcare provider for guidance on alternative treatment options. The FDA classifies this recall as Class II, indicating that use of the product may cause temporary or medically reversible health consequences.
The recalled product
- Product
- TESTOSTERONE, Pellet, 50 mg, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314
- Category
- Drug — Compounded Sterile Drug
- Affected units
- 16
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (16)
- t12292014@30
- t11202014@11
- t10132014@24
- t09042014@30
- t08252014@23
- t06292015@23
- t06252015@16
- t06052015@8
- t05162014@7
- t05072015@11
- t04302015@14
- t03102015@5
- t03052015@8
- t03032015@33
- t02182015@29
- t01092015@2.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 101 recalled by JD & SN Inc., dba Moses Lake Professional Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 101 products in this recall →Related recalls
Same manufacturer · JD & SN Inc., dba Moses Lake Professional Pharmacy
See all →- SevereFDA Recalls Estradiol Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Sodium Tetradecyl Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Six Trimix Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Compounded Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Compounded Progesterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15